Pharmasset (VRUS) Stock Research, Analysis & News
Quick Analysis on Pharmasset (VRUS) Stock as of May 18, 2012
 | The Stock pays no dividend |
 | Average trading volume is relatively low at 0 |
(See more information about Pharmasset (VRUS) Stock below)
Pharmasset (VRUS) Stock Profile Summary
Pharmasset, Inc., a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections. Its primary focus is on the development of nucleoside/tide analogs as oral therapeutics for the treatment of chronic hepatitis C virus (HCV) infection; and Racivir for the treatment of human immunodeficiency virus (HIV) infection. The company has three product candidates under development, which include RG7128, a HCV nucleoside polymerase inhibitor that is in Phase IIb clinical trial; PSI-7851, a HCV nucleotide polymerase inhibitor that completed Phase I clinical trial; and Racivir, which completed Phase II clinical trial, for the treatment of HIV. It has strategic collaboration agreement with F. Hoffmann-LaRoche Ltd. and Hoffmann-La Roche Inc. for the development of PSI-6130 and its products, including RG7128. The company also has collaboration and licensing agreements with University of Cincinnati; Apath, LLC; Emory University; Bukwang Pharm. Co., Ltd; University of Georgia Research Foundation, Inc. and Yale University; and Boehringer Ingelheim Chemicals, Inc. Pharmasset, Inc. was founded in 1998 and is based in Princeton, New Jersey.
Pharmasset (VRUS) Stock Key Statistics Research and Analysis as of May 18, 2012
| Stock Exchange | N/A |
| Trade Volume (Average Trading Volume) | 0 (0) |
Pharmasset (VRUS) Stock Competitor Research and Analysis
Mutual Funds with Pharmasset (VRUS) Stock in its top 10 holdings
ETFs with Pharmasset (VRUS) Stock in its top 10 holdings
Stock Research on Pharmasset (VRUS)
Latest Market News on Pharmasset (VRUS)
Click here to find the latest news on Pharmasset (VRUS)
Looking for Market Opportunties?
Today's Most Active Stocks
Today's Biggest Price % Gainers
Today's Biggest Price % Losers
Today's Unusual Rising Volume Stocks
Today's Unusual Falling Volume Stocks
Research Reports
Earning Calendar
ETF Center
See other companies in the same industry
Merck & Co. Inc. (MRK) Vertex Pharmaceuticals Incorporated (VRTX) Amgen Inc. (AMGN) Biogen Idec Inc. (BIIB) Genzyme Corp. (GENZ) Gilead Sciences Inc. (GILD) Life Technologies Corporation (LIFE) Teva Pharmaceutical Industries Limited (TEVA) Watson Pharmaceuticals Inc. (WPI) King Pharmaceuticals Inc. (KG) Mylan, Inc. (MYL) Pfizer Inc. (PFE) Johnson & Johnson (JNJ) GlaxoSmithKline plc (GSK) Sanofi-Aventis (SNY) Novartis AG (NVS) AstraZeneca PLC (AZN) Abbott Laboratories (ABT) Bristol-Myers Squibb Company (BMY)
Research on Pharmasset (VRUS)
